Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
August 09, 2009
Form 6-K
Source: SEC/Edgar
August 09, 2009
Form 6-K
Source: SEC/Edgar
August 06, 2009
Form 6-K
Source: SEC/Edgar
August 03, 2009
Form 6-K
Source: SEC/Edgar
July 27, 2009
Form 6-K
Source: SEC/Edgar
July 20, 2009
Form 6-K
Source: SEC/Edgar
July 13, 2009
Form 6-K
Source: SEC/Edgar
July 05, 2009
Form 6-K
Source: SEC/Edgar
July 05, 2009
Form 6-K
Source: SEC/Edgar
June 30, 2009
Form 6-K
Source: SEC/Edgar
June 29, 2009
Form 6-K
Source: SEC/Edgar
June 28, 2009
Form 6-K
Source: SEC/Edgar
June 28, 2009
Form 6-K
Source: SEC/Edgar
June 25, 2009
Form 6-K
Source: SEC/Edgar
June 21, 2009
Form 6-K
Source: SEC/Edgar
June 21, 2009
Form 6-K
Source: SEC/Edgar
June 14, 2009
Form 6-K
Source: SEC/Edgar
June 08, 2009
Form 6-K
Source: SEC/Edgar
June 02, 2009
Form 6-K
Source: SEC/Edgar
June 02, 2009
Form 6-K
Source: SEC/Edgar
May 25, 2009
Form 6-K
Source: SEC/Edgar
May 17, 2009
Form 6-K
Source: SEC/Edgar
May 12, 2009
Form 6-K
Source: SEC/Edgar
May 03, 2009
Form 6-K
Source: SEC/Edgar
April 30, 2009
Form 6-K
Source: SEC/Edgar
April 27, 2009
Form 6-K
Source: SEC/Edgar
April 23, 2009
Form 6-K
Source: SEC/Edgar
April 20, 2009
Form 6-K
Source: SEC/Edgar
April 05, 2009
Form 6-K
Source: SEC/Edgar
April 02, 2009
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.